DOI QR코드

DOI QR Code

Pear pomace ethanol extract improves insulin resistance through enhancement of insulin signaling pathway without lipid accumulation

  • You, Mi-Kyoung (Department of Food and Nutrition / Research Institute of Human Ecology, Mokpo National University) ;
  • Kim, Hwa-Jin (Department of Food and Nutrition / Research Institute of Human Ecology, Mokpo National University) ;
  • Rhyu, Jin (Department of Food and Nutrition / Research Institute of Human Ecology, Mokpo National University) ;
  • Kim, Hyeon-A (Department of Food and Nutrition / Research Institute of Human Ecology, Mokpo National University)
  • Received : 2016.10.31
  • Accepted : 2017.02.07
  • Published : 2017.06.01

Abstract

BACKGROUND/OBJECTIVES: The anti-diabetic activity of pear through inhibition of ${\alpha}-glucosidase$ has been demonstrated. However, little has been reported about the effect of pear on insulin signaling pathway in obesity. The aims of this study are to establish pear pomace 50% ethanol extract (PPE)-induced improvement of insulin sensitivity and characterize its action mechanism in 3T3-L1 cells and high-fat diet (HFD)-fed C57BL/6 mice. MATERIALS/METHODS: Lipid accumulation, monocyte chemoattractant protein-1 (MCP-1) secretion and glucose uptake were measure in 3T3-L1 cells. Mice were fed HFD (60% kcal from fat) and orally ingested PPE once daily for 8 weeks and body weight, homeostasis model assessment of insulin resistance (HOMA-IR), and serum lipids were measured. The expression of proteins involved in insulin signaling pathway was evaluated by western blot assay in 3T3-L1 cells and adipose tissue of mice. RESULTS: In 3T3-L1 cells, without affecting cell viability and lipid accumulation, PPE inhibited MCP-1 secretion, improved glucose uptake, and increased protein expression of phosphorylated insulin receptor substrate 1 [p-IRS-1, ($Tyr^{632})$)], p-Akt, and glucose transporter type 4 (GLUT4). Additionally, in HFD-fed mice, PPE reduced body weight, HOMA-IR, and serum lipids including triglyceride and LDL-cholesterol. Furthermore, in adipose tissue, PPE up-regulated GLUT4 expression and expression ratio of p-IRS-1 ($Tyr^{632})/IRS$, whereas, down-regulated p-IRS-1 ($Ser^{307})/IRS$. CONCLUSIONS: Our results collectively show that PPE improves glucose uptake in 3T3-L1 cells and insulin sensitivity in mice fed a HFD through stimulation of the insulin signaling pathway. Furthermore, PPE-induced improvement of insulin sensitivity was not accompanied with lipid accumulation.

Acknowledgement

Supported by : Ministry of Agriculture, Food and Rural Affairs

References

  1. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-6. https://doi.org/10.1038/nature05482
  2. Biddinger SB, Kahn CR. From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 2006;68:123-58. https://doi.org/10.1146/annurev.physiol.68.040104.124723
  3. Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2000;106:165-9. https://doi.org/10.1172/JCI10582
  4. Saad MJ, Araki E, Miralpeix M, Rothenberg PL, White MF, Kahn CR. Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest 1992;90:1839-49. https://doi.org/10.1172/JCI116060
  5. Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 2011;12:722-34. https://doi.org/10.1038/nrm3198
  6. Rajala MW, Scherer PE. Minireview: the adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003;144:3765-73. https://doi.org/10.1210/en.2003-0580
  7. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008;9:367-77. https://doi.org/10.1038/nrm2391
  8. White MF. Insulin signaling in health and disease. Science 2003;3 02:1710-1.
  9. Pilch PF, Lee J. Insulin receptor family. In: Lennarz WJ, Lane MD, editors. Encyclopedia of Biological Chemistry. Vol. 2. Oxford: Elsevier Academic Press; 2004. p. 436-40.
  10. Muretta JM, Mastick CC. How insulin regulates glucose transport in adipocytes. Vitam Horm 2009;80:245-86.
  11. Huang S, Czech MP. The GLUT4 glucose transporter. Cell Metab 2007;5:237-52. https://doi.org/10.1016/j.cmet.2007.03.006
  12. Xie L, Ortega MT, Mora S, Chapes SK. Interactive changes between macrophages and adipocytes. Clin Vaccine Immunol 2010;17:651-9. https://doi.org/10.1128/CVI.00494-09
  13. Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 2014;383:1068-83. https://doi.org/10.1016/S0140-6736(13)62154-6
  14. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995;270:12953-6. https://doi.org/10.1074/jbc.270.22.12953
  15. Diamant M, Heine RJ. Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence. Drugs 2003;63:1373-405. https://doi.org/10.2165/00003495-200363130-00004
  16. Nesto RW, Bell D, Bonow RO, Fonseca V, Grundy SM, Horton ES, Le Winter M, Porte D, Semenkovich CF, Smith S, Young LH, Kahn R; American Heart Association; American Diabetes Association. Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003. Circulation 2003; 108:2941-8. https://doi.org/10.1161/01.CIR.0000103683.99399.7E
  17. Bazelier MT, Gallagher AM, van Staa TP, Cooper C, Leufkens HG, Vestergaard P, de Vries F. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs? Pharmacoepidemiol Drug Saf 2012;21:507-14. https://doi.org/10.1002/pds.3234
  18. Chang CL, Lin Y, Bartolome AP, Chen YC, Chiu SC, Yang WC. Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid Based Complement Alternat Med 2013;2013:378657.
  19. Singh R, Kaur N, Kishore L, Gupta GK. Management of diabetic complications: a chemical constituents based approach. J Ethnopharmacol 2013;150:51-70. https://doi.org/10.1016/j.jep.2013.08.051
  20. Rabetafika HN, Bchir B, Blecker C, Paquot M, Wathelet B. Comparative study of alkaline extraction process of hemicelluloses from pear pomace. Biomass Bioenergy 2014;61:254-64. https://doi.org/10.1016/j.biombioe.2013.12.022
  21. Li X, Wang T, Zhou B, Gao W, Cao J, Huang L. Chemical composition and antioxidant and anti-inflammatory potential of peels and flesh from 10 different pear varieties (Pyrus spp.). Food Chem 2014;152:531-8. https://doi.org/10.1016/j.foodchem.2013.12.010
  22. Boath AS, Stewart D, McDougall GJ. Berry components inhibit ${\alpha}$ -glucosidase in vitro: synergies between acarbose and polyphenols from black currant and rowanberry. Food Chem 2012;135:929-36. https://doi.org/10.1016/j.foodchem.2012.06.065
  23. Oboh G, Ademiluyi AO, Akinyemi AJ, Henle T, Saliu JA, Schwarzenbolz U. Inhibitory effect of polyphenol-rich extracts of jute leaf (Corchorus olitorius) on key enzyme linked to type-2 diabetes (${\alpha}$-amylase and ${\alpha}$-glucosidase) and hypertension (angiotensin I converting) in vitro. J Funct Foods 2012;4:450-8. https://doi.org/10.1016/j.jff.2012.02.003
  24. Zhang L, Hogan S, Li J, Sun S, Canning C, Zheng SJ, Zhou K. Grape skin extract inhibits mammalian intestinal ${\alpha}$-glucosidase activity and suppresses postprandial glycemic response in streptozocin-treated mice. Food Chem 2011;126:466-71. https://doi.org/10.1016/j.foodchem.2010.11.016
  25. Wang T, Li X, Zhou B, Li H, Zeng J, Gao W. Anti-diabetic activity in type 2 diabetic mice and ${\alpha}$-glucosidase inhibitory, antioxidant and anti-inflammatory potential of chemically profiled pear peel and pulp extracts (Pyrus spp.). J Funct Foods 2015;13:276-88. https://doi.org/10.1016/j.jff.2014.12.049
  26. Kim J, Park Y, Yoon KS, Clark JM, Park Y. Permethrin alters adipogenesis in 3T3-L1 adipocytes and causes insulin resistance in C2C12 myotubes. J Biochem Mol Toxicol 2014;28:418-24. https://doi.org/10.1002/jbt.21580
  27. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29-33. https://doi.org/10.1161/01.ATV.0000099786.99623.EF
  28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9. https://doi.org/10.1007/BF00280883
  29. Fernandez-Veledo S, Nieto-Vazquez I, Vila-Bedmar R, Garcia-Guerra L, Alonso-Chamorro M, Lorenzo M. Molecular mechanisms involved in obesity-associated insulin resistance: therapeutical approach. Arch Physiol Biochem 2009;115:227-39. https://doi.org/10.1080/13813450903164330
  30. James DE, Brown R, Navarro J, Pilch PF. Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature 1988;333:183-5. https://doi.org/10.1038/333183a0
  31. Zhou L, Yang Y, Wang X, Liu S, Shang W, Yuan G, Li F, Tang J, Chen M, Chen J. Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism 2007;56:405-12. https://doi.org/10.1016/j.metabol.2006.10.025
  32. Garvey WT, Maianu L, Huecksteadt TP, Birnbaum MJ, Molina JM, Ciaraldi TP. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J Clin Invest 1991;87:1072-81. https://doi.org/10.1172/JCI115068
  33. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106:473-81. https://doi.org/10.1172/JCI10842
  34. Buettner R, Scholmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 2007;15:798-808. https://doi.org/10.1038/oby.2007.608
  35. Song H, Han W, Yan F, Xu D, Chu Q, Zheng X. Dietary Phaseolus vulgaris extract alleviated diet-induced obesity, insulin resistance and hepatic steatosis and alters gut microbiota composition in mice. J Funct Foods 2016;20:236-44. https://doi.org/10.1016/j.jff.2015.10.022
  36. Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA. A mouse model of metabolic syndrome: Insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 2010;46:212-23. https://doi.org/10.3164/jcbn.09-83
  37. Tsai CW, Liu KL, Lin YR, Kuo WC. The mechanisms of carnosic acid attenuates tumor necrosis factor-${\alpha}$-mediated inflammation and insulin resistance in 3T3-L1 adipocytes. Mol Nutr Food Res 2014;58: 654-64. https://doi.org/10.1002/mnfr.201300356
  38. Hwang JS, Park JW, Nam MS, Cho H, Han IO. Glucosamine enhances body weight gain and reduces insulin response in mice fed chow diet but mitigates obesity, insulin resistance and impaired glucose tolerance in mice high-fat diet. Metabolism 2015;64:368-79. https://doi.org/10.1016/j.metabol.2014.11.005
  39. Williams VL, Martin RE, Franklin JL, Hardy RW, Messina JL. Injuryinduced insulin resistance in adipose tissue. Biochem Biophys Res Commun 2012;421:442-8. https://doi.org/10.1016/j.bbrc.2012.03.146
  40. Araujo TG, de Oliveira AG, Vecina JF, Marin RM, Franco ES, Abdalla Saad MJ, de Sousa Maia MB. Parkinsonia aculeata (Caesalpineaceae) improves high-fat diet-induced insulin resistance in mice through the enhancement of insulin signaling and mitochondrial biogenesis. J Ethnopharmacol 2016;183:95-102. https://doi.org/10.1016/j.jep.2016.02.048
  41. Yamashita H, Kusudo T, Takeuchi T, Qiao S, Tsutsumiuchi K, Wang T, Wang Y. Dietary supplementation with evodiamine prevents obesity and improves insulin resistance in ageing mice. J Funct Foods 2015;19:320-9. https://doi.org/10.1016/j.jff.2015.09.032

Cited by

  1. Pulliat is Associated with the Activation of AMPK Signaling Pathway vol.34, pp.1, 2018, https://doi.org/10.5487/TR.2018.34.1.013
  2. Induction of Apoptosis by Citrus unshiu Peel in Human Breast Cancer MCF-7 Cells: Involvement of ROS-Dependent Activation of AMPK vol.41, pp.5, 2018, https://doi.org/10.1248/bpb.b17-00898
  3. peel in MDA-MB-231 human breast carcinoma cells vol.12, pp.2, 2018, https://doi.org/10.4162/nrp.2018.12.2.129